Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women
- PMID: 22792352
- PMCID: PMC3394707
- DOI: 10.1371/journal.pone.0040494
Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women
Abstract
Genetic variants in hormone receptor genes may be crucial predisposing factors for breast cancer, and microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes have been suggested to play a role. We studied 258 African-American (AA) women with breast cancer and 259 hospital-based controls, as well as 349 Nigerian (NG) female breast cancer patients and 296 community controls. Three microsatellites, ESR1_TA, ESR2_CA and AR_CAG, in the ESR1, ESR2 and AR genes, respectively, were genotyped. Their repeat lengths were then analyzed as continuous and dichotomous variables. Analyses of continuous variables showed no association with breast cancer risk in either AA or NG at ESR1_TA; AA cases had shorter repeats in the long allele of ESR2_CA than AA controls (Mann-Whitney P= 0.036; logistic regression P = 0.04, OR= 0.91, 95% CI 0.83-1.00), whereas NG patients had longer repeats in the short allele than NG controls (Mann-Whitney P= 0.0018; logistic regression P= 0.04, OR= 1.06, 95% CI 1.00-1.11); and AA cases carried longer repeats in the short allele of AR_CAG than AA controls (Mann-Whitney P= 0.038; logistic regression P = 0.03, OR= 1.08, 95% CI 1.01-1.15). When allele sizes were categorized as dichotomous variables, we discovered that women with two long alleles of ESR2_CA had increased risk of breast cancer (OR = 1.38, 95% CI 1.10-1.74; P = 0.006). This is the first study to investigate these three microsatellites in hormonal receptor genes in relation to breast cancer risk in an indigenous African population. After adjusting for multiple-testing, our findings suggest that ESR2_CA is associated with breast cancer risk in Nigerian women, whereas ESR1_TA and AR_CAG seem to have no association with the disease among African American or Nigerian women.
Conflict of interest statement
Figures

Similar articles
-
Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.Breast. 2008 Apr;17(2):159-66. doi: 10.1016/j.breast.2007.08.007. Epub 2007 Sep 29. Breast. 2008. PMID: 17904846
-
Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.Int J Cancer. 2010 Jun 15;126(12):2935-46. doi: 10.1002/ijc.24892. Int J Cancer. 2010. PMID: 19739075
-
Microsatellite variation of ESR1, ESR2, and AR in Serbian women with primary ovarian insufficiency.Climacteric. 2018 Oct;21(5):472-477. doi: 10.1080/13697137.2018.1476967. Epub 2018 Aug 29. Climacteric. 2018. PMID: 30156935
-
Association of polymorphisms in estrogen receptors (ESR1 and ESR2) with male infertility: a meta-analysis and systematic review.J Assist Reprod Genet. 2014 May;31(5):601-11. doi: 10.1007/s10815-014-0212-5. Epub 2014 Mar 20. J Assist Reprod Genet. 2014. PMID: 24647635 Free PMC article.
-
Single nucleotide polymorphisms of estrogen receptors are risk factors for the progression of adolescent idiopathic scoliosis: a systematic review and meta-analyses.J Orthop Surg Res. 2024 Sep 28;19(1):605. doi: 10.1186/s13018-024-05102-2. J Orthop Surg Res. 2024. PMID: 39342385 Free PMC article.
Cited by
-
Authorship Patterns in Cancer Genomics Publications Across Africa.JCO Glob Oncol. 2021 May;7:747-755. doi: 10.1200/GO.20.00552. JCO Glob Oncol. 2021. PMID: 34033494 Free PMC article.
-
CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies.Onco Targets Ther. 2015 Aug 13;8:2111-20. doi: 10.2147/OTT.S85130. eCollection 2015. Onco Targets Ther. 2015. PMID: 26316780 Free PMC article. Review.
-
Estrogen receptor 1 gene polymorphisms are associated with metabolic syndrome in postmenopausal women in China.BMC Endocr Disord. 2018 Sep 14;18(1):65. doi: 10.1186/s12902-018-0289-4. BMC Endocr Disord. 2018. PMID: 30217154 Free PMC article.
-
Associations of two common genetic variants with breast cancer risk in a chinese population: a stratified interaction analysis.PLoS One. 2014 Dec 22;9(12):e115707. doi: 10.1371/journal.pone.0115707. eCollection 2014. PLoS One. 2014. PMID: 25531440 Free PMC article.
-
Arrabidaea chica chloroform extract modulates estrogen and androgen receptors on luminal breast cancer cells.BMC Complement Med Ther. 2022 Jan 20;22(1):18. doi: 10.1186/s12906-022-03506-3. BMC Complement Med Ther. 2022. PMID: 35057779 Free PMC article.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. - PubMed
-
- Jemal A, Bray F, Forman D, O’Brien M, Ferlay J, et al. Cancer burden in Africa and opportunities for prevention. Cancer. 2012. doi: 10.1002/cncr.27410. - DOI - PubMed
-
- Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev. 1993;15:48–65. - PubMed
-
- Russo J, Russo IH. Genotoxicity of steroidal estrogens. Trends Endocrinol Metab. 2004;15:211–214. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous